Over the past two decades, we've worked hard to understand the very complex issue of tobacco harm reduction and invested in multiple avenues to find solutions. My role focuses on developing scientific strategies to advance tobacco harm reduction and conducting research for regulatory filings.
I'm a physician by training. I joined Altria almost 17 years ago and was hired, specifically, to work on this issue. As a physician, I knew all too well the harm caused by smoking – I had firsthand experience treating the patients who were suffering from smoking-related diseases. I also knew that the best way to avoid harm from smoking is – and has always been – to either never start or quit tobacco all together. But the reality is that not every smoker is either willing to, or can, quit smoking. So, I was motivated to find real solutions for those individuals.
We know that offering products that deliver a satisfying nicotine experience without burning tobacco or inhaling smoke — the primary link to diseases associated with smoking — is the right thing to do. We also know that one size does not fit all. Therefore, providing multiple alternatives, such as heat-not-burn, e-vapor or oral tobacco is necessary to meet the preferences of adult tobacco consumers and support them on their journeys. If we get this right, we can have a significant positive impact on public health and the health of individual smokers. And this is what I was trained to do.
We are investing in science to arrive at the right insights, guide product development and generate the data needed to really push the whole field forward. I'm excited by my work, and proud and humbled to work with world-class scientists, engineers, product development and regulatory affairs professionals who come to work every day committed to tobacco harm reduction. I firmly believe that the work that we do today will transform the tobacco industry and will have significant benefits for public health.